Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Adobe | ADBE | Jan 17, 2025 | 429.99 | +0.72 |
ADS-TEC | ADSE | Jan 17, 2025 | 15.61 | +3.65 |
ADT | ADT | Jan 17, 2025 | 7.27 | +0.69 |
Adtalem Global Education | ATGE | Jan 17, 2025 | 98.17 | +0.85 |
ADTRAN | ADTN | Jan 17, 2025 | 10.19 | +0.59 |
Aduro Clean Technologies | ADUR | Jan 17, 2025 | 5.36 | 0.00 |
Advance Auto Parts | AAP | Jan 17, 2025 | 45.91 | +0.39 |
Advanced Drainage Systems | WMS | Jan 17, 2025 | 125.49 | +1.23 |
Advanced Energy Industries | AEIS | Jan 17, 2025 | 121.16 | +1.25 |
Advanced Flower Capital | AFCG | Jan 17, 2025 | 8.62 | +2.13 |
Advanced Micro Devices | AMD | Jan 17, 2025 | 121.46 | +2.55 |
AdvanSix | ASIX | Jan 17, 2025 | 31.58 | +2.33 |
Advantage Solutions A | ADV | Jan 17, 2025 | 2.52 | +3.70 |
Advent | AVK | Jan 17, 2025 | 12.15 | +0.25 |
Advent Technologies A | ADN | Jan 17, 2025 | 6.96 | +4.04 |
Adverum Biotechnologies | ADVM | Jan 17, 2025 | 4.33 | +0.93 |
AdvisorShares Pure US Cannabis ETF | MSOS | Jan 17, 2025 | 3.59 | +4.66 |
Advisorshares Star Global Buy-Write ETF | VEGA | Jan 17, 2025 | 43.78 | +0.75 |
AECOM | ACM | Jan 17, 2025 | 108.93 | +1.00 |
Aegon N.V ADR | AEG | Jan 17, 2025 | 6.37 | +0.95 |
Aehr Test Systems | AEHR | Jan 17, 2025 | 12.46 | +2.38 |
Aemetis | AMTX | Jan 17, 2025 | 2.84 | +4.03 |
Aeon Biopharma | AEON | Jan 17, 2025 | 0.15 | -9.89 |
AerCap Holdings | AER | Jan 17, 2025 | 95.70 | -0.11 |
Aeries Technology | AERT | Jan 17, 2025 | 0.83 | -0.30 |
Aerospace & Defense Powershares | PPA | Jan 17, 2025 | 119.51 | +0.68 |
Aerovate Therapeutics | AVTE | Jan 17, 2025 | 2.58 | +6.17 |
AeroVironment | AVAV | Jan 17, 2025 | 168.74 | +2.03 |
AerSale | ASLE | Jan 17, 2025 | 6.55 | +1.55 |
AES | AES | Jan 17, 2025 | 11.82 | -1.50 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.